Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Sankyo prepares ACAT inhibitors

March 26, 1997

Bone-selective estrogen derivatives claimed by Sumitomo

March 25, 1997

Yakult Honsha discloses ACAT inhibitors

March 25, 1997

New drug therapy for erectile dysfunction more effective than PGE1

March 24, 1997

Lilly to discontinue or alter rHb1.1 collaboration with Somatogen

March 21, 1997

FDA clears Skelid

March 21, 1997

Amylin and J&J broaden collaboration

March 20, 1997

Collaboration formed to identify chronic anemia treatment

March 20, 1997

Phase II trial of Leukine as adjuvant for advanced melanoma

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...